Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACOPP vs ABVD in Stage III/IV Hodgkin's Lymphoma
NCT00049595Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 2002
- Primary completion
- Jan 2010
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine in Hodgkin lymphoma (HL), sponsored by European Organisation for Research and Treatment of Cancer. Started Aug 2002; status: completed.
02
Drugs
bleomycinetoposidedoxorubicincyclophosphamidevincristine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00049595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049595.